34
Antibiotic Resistance What Can We Do ? Dr.T.V.Rao MD Dr.T.V.Rao MD 1

Dr.T.V.Rao MD 1. The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Embed Size (px)

Citation preview

Page 1: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 1

Antibiotic Resistance

What Can We Do ?

Dr.T.V.Rao MD

Page 2: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 2

The emerging clinical impact of

antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial Resistance is a Priority . However, at the same time, a clear research agenda highlighting the most important current knowledge gaps needs to be defined to guide the direction of future research efforts.

Antimicrobial Resistance

Page 3: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 3

ß-lactams B-lactamases, altered PBP, efflux Macrolides MLS, efflux Aminoglycosides AME, permeability Fluoroquinolones altered topoisomerases,

efflux Tetracycline's efflux, altered target Chloramphenicol CAT, efflux Sulfonamides altered dihydropteroate synthase Trimethoprim altered dihydrofolate reductase Vancomycin bypass pathway Streptogramins MLS, efflux, enzyme

modification Rifampicin altered target

Antibiotics and Mechanisms of

Resistance

Page 4: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 4

Genetic diversity – nucleotide substitution, DNA rearrangements and

gene acquisition • Gene acquisition – transformation, transduction and conjugation • Mobile genetic elements – gene cassettes – integrons – insertion sequence elements and transposons – plasmids

Genetics of Antimicrobial

Resistance

Page 5: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 5

Enormous biomass of

microorganisms • Genetic plasticity • Antibiotics are microbial products, organisms

have seen them before!

• *Excessive antibiotic use • World wide travel • *Lax infection control practices

Why Are ResistantInfections Happening?

Page 6: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 6

How Much Antibiotics ? 22,000 t

11,000 t dispensed to humans (50%) in 150 million prescriptions

written annually by physicians

8 -10,000 t given to animals (40%) to treat or prevent infections mixed into feed to promote growth of agricultural

animals

20-30 t Plant (0.1%)

30-200 t Aquaculture (1%)

Page 7: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 7

Drugs for Human Treatment

are Excreted into Sewage Some drugs

excreted in metabolized amounts via the urine and feces

Some yield bioactive metabolites.

Some excreted as conjugates

Page 8: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 8

Metabolism of Antibiotics

Page 9: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 9

Veterinary Medicines in the Environment

Page 10: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 10

Antimicrobial Prescribing Facts

1/3 of all hospitalised inpatients at any given time receive antibiotics

~ up to 1/3 to ½ are inappropriate ~ up to 30% of all surgical prophylaxis in

inappropriate Antimicrobials account for upwards of

30% of hospital pharmacy budgets. Stewardship programmes can save up to 10% of pharmacy budgets.

Inappropriate and excessive use leads to resistance, C.difficle & other ecological consequences , increased morbidity, mortality,increased cost, increased litigation and reduce quality of life

Page 11: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 11

Why So Many Mistakes

High number and complexity of drugs

High number and complexity of syndromes and pathogens

Poor training in antibiotic use

Variability over time and place in- pathogen prevalence- antibiotic susceptibilities- antibiotic formularies

Page 12: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 12

Hospital acquired infections cause of many

Deaths Every year, many

lives are lost because of the spread of infections in hospitals. Health care workers can take steps to prevent the spread of infectious disease

Page 13: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 13

Biomedical research Health policy and systemsresearch

Social sciences andbehavioral research

Operational research

Basic research:physical and biological

sciences includingchemistry,

pharmacology, toxicology,

genetics, etc

Research onpolicy formulation, relationship

to evidence,prioritization, etc

R&D for drugs, vaccines,

diagnostics, appliances, etc

Research onhealth systems management,

functions, efficiency, effectiveness, system factors

affecting accessscale-up, monitoring and

evaluation, etc

Research onsocial and behavioural

factors influencing health and their relation

to equity, access, lifestyle and health-seeking behaviours,

etc

Research onfactors

affecting functioning of

programs, effectiveness of

targeting, impact on behavior, disease

burdens and public health,

etc

Understanding the biological nature of diseases; creating

products to prevent or treat disease states

Understanding how to test, scale-up and follow through the introduction of interventions and optimize their benefits

InnovationImpact

The spectrum of health research

Page 14: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 14

Ongoing effort by a health care institution to

optimize antimicrobial use among hospitalized patients to ...

- Improve patient outcomes - Ensure cost-effective therapy,

and - Reduce adverse sequelae of

antimicrobial use (including antimicrobial resistance).

What is Antimicrobial Stewardship

Page 15: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 15

What Can We Do?Strengthen our Microbiology

Departments ?

Keep aware National/

Provincial Surveillance Programs

Get to know your microbiology laboratory

Page 16: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 16

What Can We Do?

–Expect rapid turn around times

– Appropriate susceptibility test reporting

Page 17: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 17

What Can We Do?

Infection Control in the office & hospital

• Decrease antibiotic prescriptions for viral URI’s by half!

• Improve communication with patients

Page 18: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 18

Hand Washing a must for Safety of our

Patients Proper hand washing

is the most effective way to prevent the spread of infections in hospitals. If you are a patient, don't be afraid to remind friends, family and health care providers to wash their hands before getting close to you.

Page 19: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 19

Preventive Measures ….

Covering coughs and sneezes Staying up-to-date with immunizations Using gloves, masks and protective clothing Making tissues and hand cleaners available Following hospital guidelines when dealing with blood or contaminated items

Page 20: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 20

Organize your Clinical Microbiology Laboratory

Bench Microbiologists

should bring in change with dedication to bench work, and Proficiency Testing to improve the quality to services in Health care

Page 21: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 21

What most Proficiency Testing

does not tend to look at: Are negative samples reported as negative? Are contaminated samples reported as

contaminated? Are complex samples submitted for referral? Are pre-analytic factors addressed?

Improper containers and transport Outdated samples. Mislabeled samples. Rejection criteria

Are post-analytic factors addressed? Interpretive commentary included

Page 22: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 22

PT providers should publish scientifically credible reports in peer-reviewed journals.

Ensure all clinical laboratories participate in PT, including waved tests.

Develop a methodology-based approach for PT (one material for many assays).

Samples should mimic patient samples with a minimum of matrix effect.

Small adjunct studies with fresh frozen samples in conjunction with “routine” PT.

Evaluate alternatives to current CLIA requirements for frequency and scoring.

Develop innovative approaches to PT.

CDC ReportApril 2008

Page 23: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 23

Does Proficiency Testing improve

quality? Probably yes, but hard to

prove. Accredited programs do

better on PT Laboratories with

consistently high PT performance do better with accreditation

Clinical Error? Clinical error detection? OFIs and Continual

Improvement?

Page 24: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 24

Medical laboratory proficiency testing

Medical laboratory proficiency testing has been around for 60 years

Respected as a valued monitoring tool Inter-laboratory comparisons Internal audit Inter-technologist education

Starting to show its age Testing the wrong thing in the wrong way Falling behind laboratory reality

Page 25: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 25

What is Antimicrobial Stewardship?

A marriage of infection control and antimicrobial management

Mandatory infection control compliance Selection of antimicrobials from each class of drugs

that does the least collateral damage Collateral damage issues include

- MRSA- ESBLs- C.difficile- stable DE repression- MBLs and other carbapenemases- VRE

Appropriate de-escalation when culture results are available Dellit TH et al Clin Infect Dis 2007; 44: 159-177

Page 26: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 26

A. Be able to list the recommended

components of an antibiotic stewardship program

B. Be able to detect antibiotic use improvement opportunities from the analysis of utilization data

C. Be able to explain the barriers for successful implementation of such a program

Objectives for Starting Antibiotic Stewardship

Page 27: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 27

Why Develop an Antimicrobial Stewardship

ProgramFrom an Infection Preventionist

Perspective:

Track and Reduce antimicrobial resistance

Encourage appropriate treatment patterns ~ The right antibiotic, for the right duration

Develop a collaborative practice between MDs/LIPs, Pharmacy, Laboratories and Infection Preventionists’ with best patient outcome in mind.

Page 28: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 28

WORKSTREAMS

1. INFORMATION MANAGEMENT (HPS AND ISD)

2. EDUCATION (NES)

3.ORGANISATION AND ACCOUNTABILITY (NQIS)

Page 29: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 29

4.INFECTION MANAGEMENT

(SPA,NQIS,NES,HPS-ISD, Professional Organisations) All the work-streams work in

parallel but with vertical integration

Work stream work underpinned by an AMT Clinical Network

WORKSTREAMS

Page 30: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 30

INFECTION MANAGMENT PHILOSOPHY

HIGH BURDEN, HIGH IMPACT CONDITIONS EVIDENCE OF BENEFIT FOR INTERVENTION ALSO TARGET SYSTEMS CHANGE TO BRING

ABOUT DESIRED BENEFIT INTEGRATE, DEVELOP AND IMPLEMENT

EXISITING AND NEW PROJECTS OVER 3 YEAR TIME FRAME: WORK CLOSELY WITH WORK PROGRAMMES OF KEY STAKEHOLDERS (e.g HPS, SPA)

IMMEDIATE OPPORTUNITIES AROUND SNAP-CAP, C.difficle and Surgical Prophylaxis.

Page 31: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 31

Assist providers in appropriate use of

antimicrobial therapy with improved patient outcomes

Slow the development of antimicrobial resistance

Develop evidence- based appropriate use guidelines

Educate providers and staff regarding guidelines

Track resistance patterns and report back to medical and hospital staff

Report committee progress and outcomes to P&T, and Executive Committees

Goals of Committee

Page 32: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 32

Clean Hands Saves Many Lives

Page 33: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 33

Follow me for more topics of Interest on Infectious

Diseases

Page 34: Dr.T.V.Rao MD 1.   The emerging clinical impact of antimicrobial resistance, urgent implementation of the Global Strategy for the Containment of Antimicrobial

Dr.T.V.Rao MD 34

Programme Created by Dr.T.V.Rao

MD for Awareness on Use and Misuse of Antibiotics by Medical

Professionals

[email protected]